Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56701 - 56725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	SLCO4C1	353189	upregulated	panobinostat results in increased expression of SLCO4C1 mRNA	5q21.1	A21037
Panobinostat	Approved Investigational	SLIT1	6585	upregulated	panobinostat results in increased expression of SLIT1 mRNA	10q24.1	A21037
Panobinostat	Approved Investigational	SLIT2	9353	upregulated	panobinostat results in increased expression of SLIT2 mRNA	4p15.31	A21037
Panobinostat	Approved Investigational	SLIT3	6586	upregulated	panobinostat results in increased expression of SLIT3 mRNA	5q34-q35.1	A21037
Panobinostat	Approved Investigational	SLITRK6	84189	upregulated	panobinostat results in increased expression of SLITRK6 mRNA	13q31.1	A21037
Panobinostat	Approved Investigational	SMAD2	4087	downregulated	panobinostat results in decreased expression of SMAD2 mRNA	18q21.1	A21037
Panobinostat	Approved Investigational	SMARCA2	6595	upregulated	panobinostat results in increased expression of SMARCA2 mRNA	9p24.3	A21037
Panobinostat	Approved Investigational	SMOC1	64093	downregulated	panobinostat results in decreased expression of SMOC1 mRNA	14q24.1	A21037
Panobinostat	Approved Investigational	SMYD2	56950	upregulated	panobinostat results in increased expression of SMYD2 mRNA	1q32.3	A21037
Panobinostat	Approved Investigational	SNAI2	6591	upregulated	panobinostat results in increased expression of SNAI2 mRNA	8q11.21	A21037
Panobinostat	Approved Investigational	SNAP25	6616	upregulated	panobinostat results in increased expression of SNAP25 mRNA	20p12.2	A21037
Panobinostat	Approved Investigational	SNX25	83891	downregulated	panobinostat results in decreased expression of SNX25 mRNA	4q35.1	A21037
Panobinostat	Approved Investigational	SOCS1	8651	upregulated	panobinostat results in increased expression of SOCS1 mRNA	16p13.13	A21037
Panobinostat	Approved Investigational	SOCS2	8835	upregulated	panobinostat results in increased expression of SOCS2 mRNA	12q	A21037
Panobinostat	Approved Investigational	SOCS3	9021	downregulated	panobinostat results in decreased expression of SOCS3 mRNA	17q25.3	A21037
Panobinostat	Approved Investigational	SORCS2	57537	downregulated	panobinostat results in decreased expression of SORCS2 mRNA	4p16.1	A21037
Panobinostat	Approved Investigational	SORD	6652	downregulated	panobinostat results in decreased expression of SORD mRNA	15q21.1	A21037
Panobinostat	Approved Investigational	SOX10	6663	upregulated	panobinostat results in increased expression of SOX10 mRNA	22q13.1	A21037
Panobinostat	Approved Investigational	SOX11	6664	downregulated	panobinostat results in decreased expression of SOX11 mRNA	2p25.2	A21037
Panobinostat	Approved Investigational	SOX2	6657	downregulated	panobinostat results in decreased expression of SOX2 mRNA	3q26.33	A21037
Panobinostat	Approved Investigational	SOX21-AS1	100507533	downregulated	panobinostat results in decreased expression of SOX21-AS1 mRNA	13q32.1	A21037
Panobinostat	Approved Investigational	SOX2-OT	347689	downregulated	panobinostat results in decreased expression of SOX2-OT mRNA	3q26.33	A21037
Panobinostat	Approved Investigational	SOX3	6658	downregulated	panobinostat results in decreased expression of SOX3 mRNA	Xq27.1	A21037
Panobinostat	Approved Investigational	SOX8	30812	upregulated	panobinostat results in increased expression of SOX8 mRNA	16p13.3	A21037
Panobinostat	Approved Investigational	SOX9	6662	upregulated	panobinostat results in increased expression of SOX9 mRNA	17q24.3	A21037

Displaying entries 56701 - 56725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability